Abstract
This cross-sectional study aimed to examine financial toxicity among people with skin cancer using pooled National Health Interview Survey data from adults in 2011–2018. Material, behavioral, and psychological markers of financial toxicity were compared by lifetime skin cancer history (any melanoma, any skin cancer beside melanoma, and no skin cancer) using multivariable logistic regression models. Of 257,652 total participants, 1874 (0.73%) had known melanoma and 7073 (2.75%) had any skin cancer beside melanoma. History of skin cancers was not independently associated with increased markers of financial toxicity after adjustment for sociodemographic and medical co-morbidities.
References
NHIS Data, Questionnaires and Related Documentation. https://www-cdc-gov.proxy.library.emory.edu/nchs/nhis/about_nhis.htm. Published 2020. Accessed February 20, 2021.
Guy GP Jr, Machlin SR, Ekwueme DU, Yabroff KR (2015) Prevalence and costs of skin cancer treatment in the U.S., 2002–2006 and 2007–2011. Am J Prev Med 48(2):183–187
Lentz R, Benson AB 3rd, Kircher S (2019) Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies. J Surg Oncol 120(1):85–92
Ming ME, Levy RM, Hoffstad OJ, Filip J, Gimotty PA, Margolis DJ (2004) Validity of patient self-reported history of skin cancer. Arch Dermatol 140(6):730–735
Yabroff KR, Zhao J, Han X, Zheng Z (2019) Prevalence and Correlates of Medical Financial Hardship in the USA. J Gen Intern Med 34(8):1494–1502
Funding
Dr. Yeung is supported in part by Developmental Funds from the Winship Cancer Institute of Emory University and by the National Institute of Arthritis and Musculoskeletal and Skin Diseases under award numbers L30AR076081 and K23AR075888. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Department of Veterans Affairs.
Author information
Authors and Affiliations
Contributions
All authors made substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, been involved in drafting the manuscript and revised it critically for important intellectual content and gave final approval of the version to be published. All authors agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
Dr. Chen receives royalties from for-profit companies that license quality of life instruments for which Emory holds copyright. Dr. Supapannachart and Ms. Chu have no conflicts of interest to declare.
Ethical approval
Exempt.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Prior presentation: Study abstract has been accepted as a poster presentation at the Society of Investigative Dermatology meeting in Portland, OR on May 20, 2022.
Rights and permissions
About this article
Cite this article
Supapannachart, K.J., Chu, L., Chen, S.C. et al. Financial toxicity and skin cancer care in the US: population-based survey from 2011 to 2018. Arch Dermatol Res 315, 2171–2174 (2023). https://doi.org/10.1007/s00403-023-02581-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02581-x